Clinical application value of small-for-size left lobe liver auxiliary partial orthotopic liver transplantation for treatment of decompensated cirrhosis_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

TANG Gang ^1,2 , KONG Lingxiang ^1,2 ,  YANG Jiayin ^1,2

1. Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding?author：

YANG Jiayin, Email: doctoryjy@scu.edu.cn

Keywords：

auxiliary partial orthotopic liver transplant; decompensated cirrhosis; small-for-size graft; hepatitis B

DOI：

10.7507/1007-9424.202410018

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the clinical value of small-for-size left lobe liver auxiliary partial orthotopic liver transplantation (APOLT) in the treatment of decompensated cirrhosis. Method The preoperative and postoperative clinical data of 4 patients who received small-for-size left lobe liver APOLT in 2023 were retrospectively described and analyzed. Results One patient suffered metabolic liver disease cirrhosis and the other three suffered hepatitis B cirrhosis, all of whom presented with decompensated cirrhosis. Preoperative evaluation showed that the graft-to-recipient weight ratio was less than 0.6%. All recipients underwent left hemihepatectomy. The grafts were derived from living donors in 3 cases, from donation after citizen death in 1 case. After APOLT treatment, 4 patients and grafts survived, 1 patient experienced transplantation rejection and recovered after modified anti-rejection therapy. Three patients with hepatitis B cirrhosis were treated with nucleoside analogues and hepatitis B immunoglobulin, the hepatitis B virus DNA was negative at the end of follow-up, one of three patients with hepatitis B cirrhosis showed negative results for hepatitis B virus in the graft biopsy at month one after surgery. Conclusions From the summary results of these cases, small-for-size left lobe liver APOLT can be used to treat decompensated cirrhosis. The application and popularization of this treatment regimen is expected to expand the donor pool and benefit more decompensated cirrhosis patients with lower Model for End-stage Liver Disease score.

Citation： TANG Gang, KONG Lingxiang, YANG Jiayin. Clinical application value of small-for-size left lobe liver auxiliary partial orthotopic liver transplantation for treatment of decompensated cirrhosis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2025, 32(3): 313-318. doi: 10.7507/1007-9424.202410018 Copy

1.	Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol, 2023, 79(2): 516-537.
2.	Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol, 2023, 20(8): 524-537.
3.	戴二黑, 郭心如, 王繼濤, 等. 肝硬化的病因及防治現狀調查. 中華醫學雜志, 2023, 103(12): 913-919.
4.	Hui AY, Chan HL, Leung NW, et al. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol, 2002, 34(5): 569-572.
5.	D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol, 2006, 44(1): 217-231.
6.	王海波, 史贏, 周稚燁, 等. 2019年中國器官捐獻與移植等待現狀分析. 中華器官移植雜志, 2021, 42(6): 324-325.
7.	呂濤, 徐崗, 徐西, 等. 華西雙供體肝臟移植專家共識. 中國普外基礎與臨床雜志, 2024, 31(4): 385-388.
8.	Kim SH, Kim KH, Cho HD. Donor safety of remnant liver volumes of less than 30% in living donor liver transplantation: A systematic review and meta-analysis. Clin Transplant, 2023, 37(9): e15080. doi: 10.1111/ctr.15080.
9.	Feng Y, Han Z, Wang X, et al. Association of graft-to-recipient weight ratio with the prognosis following liver transplantation: a meta-analysis. J Gastrointest Surg, 2020, 24(8): 1869-1879.
10.	Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant, 2015, 15(1): 17-38.
11.	Rela M, Kaliamoorthy I, Reddy MS. Current status of auxiliary partial orthotopic liver transplantation for acute liver failure. Liver Transpl, 2016, 22(9): 1265-1274.
12.	Shanmugam NP, Valamparampil JJ, Reddy MS, et al. Auxiliary partial orthotopic liver transplantation for monogenic metabolic liver diseases: single-centre experience. JIMD Rep, 2019, 45: 29-36.
13.	Inomata Y, Kiuchi T, Kim I, et al. Auxiliary partial orthotopic living donor liver transplantation as an aid for small-for-size grafts in larger recipients. Transplantation, 1999, 67(10): 1314-1319.
14.	ten Kate FJ, Schalm SW, Willemse PJ, et al. Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunohistochemical study. J Hepatol, 1992, 14(2-3): 168-175.
15.	Chen J, Yi L, Jia JD, et al. Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review. J Gastroenterol Hepatol, 2010, 25(5): 872-879.
16.	Scatton O, Azoulay D, Castaing D, et al. Auxiliary partial orthotopic liver transplantation using small grafts. A way to avoid small-for-size syndrome?. Gastroenterol Clin Biol, 2005, 29(1): 76-79.
17.	Cho JY, Suh KS, Kwon CH, et al. Auxiliary partial orthotopic living donor liver transplantation in a patient with alcoholic liver cirrhosis to overcome donor steatosis. Transpl Int, 2006, 19(5): 424-429.
18.	朱志軍, 魏林, 張海明, 等. 小體積移植物輔助性肝移植治療門靜脈高壓癥的臨床效果. 中華外科雜志, 2023, 61(3): 220-226.
19.	中華醫學會器官移植學分會, 中國醫師協會器官移植醫師分會. 中國活體肝移植供者微創手術技術指南(2024年版). 中國普外基礎與臨床雜志, 2024, 31(3): 285-296.
20.	Ge J, Perito ER, Bucuvalas J, et al. Split liver transplantation is utilized infrequently and concentrated at few transplant centers in the United States. Am J Transplant, 2020, 20(4): 1116-1124.
21.	Hu TH, Chen CL, Lin CC, et al. Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation. Transplantation, 2014, 97 Suppl 8: S53-S59.
22.	Mehrabi A, Esmaeilzadeh M, Fonouni H, et al. The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation. Langenbecks Arch Surg, 2012, 397(5): 697-710.
23.	Wang SF, Chen XP, Chen ZS, et al. Left lobe auxiliary liver transplantation for end-stage hepatitis B liver cirrhosis. Am J Transplant, 2017, 17(6): 1606-1612.
24.	Wei L, Zhang HM, Wan CD, et al. Auxiliary liver graft can be protected from HBV infection in HBsAg positive blood circulation. Front Med (Lausanne), 2021, 8: 726502. doi: 10.3389/fmed.2021.726502.

1. Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol, 2023, 79(2): 516-537.
2. Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol, 2023, 20(8): 524-537.
3. 戴二黑, 郭心如, 王繼濤, 等. 肝硬化的病因及防治現狀調查. 中華醫學雜志, 2023, 103(12): 913-919.
4. Hui AY, Chan HL, Leung NW, et al. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol, 2002, 34(5): 569-572.
5. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol, 2006, 44(1): 217-231.
6. 王海波, 史贏, 周稚燁, 等. 2019年中國器官捐獻與移植等待現狀分析. 中華器官移植雜志, 2021, 42(6): 324-325.
7. 呂濤, 徐崗, 徐西, 等. 華西雙供體肝臟移植專家共識. 中國普外基礎與臨床雜志, 2024, 31(4): 385-388.
8. Kim SH, Kim KH, Cho HD. Donor safety of remnant liver volumes of less than 30% in living donor liver transplantation: A systematic review and meta-analysis. Clin Transplant, 2023, 37(9): e15080. doi: 10.1111/ctr.15080.
9. Feng Y, Han Z, Wang X, et al. Association of graft-to-recipient weight ratio with the prognosis following liver transplantation: a meta-analysis. J Gastrointest Surg, 2020, 24(8): 1869-1879.
10. Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant, 2015, 15(1): 17-38.
11. Rela M, Kaliamoorthy I, Reddy MS. Current status of auxiliary partial orthotopic liver transplantation for acute liver failure. Liver Transpl, 2016, 22(9): 1265-1274.
12. Shanmugam NP, Valamparampil JJ, Reddy MS, et al. Auxiliary partial orthotopic liver transplantation for monogenic metabolic liver diseases: single-centre experience. JIMD Rep, 2019, 45: 29-36.
13. Inomata Y, Kiuchi T, Kim I, et al. Auxiliary partial orthotopic living donor liver transplantation as an aid for small-for-size grafts in larger recipients. Transplantation, 1999, 67(10): 1314-1319.
14. ten Kate FJ, Schalm SW, Willemse PJ, et al. Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunohistochemical study. J Hepatol, 1992, 14(2-3): 168-175.
15. Chen J, Yi L, Jia JD, et al. Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review. J Gastroenterol Hepatol, 2010, 25(5): 872-879.
16. Scatton O, Azoulay D, Castaing D, et al. Auxiliary partial orthotopic liver transplantation using small grafts. A way to avoid small-for-size syndrome?. Gastroenterol Clin Biol, 2005, 29(1): 76-79.
17. Cho JY, Suh KS, Kwon CH, et al. Auxiliary partial orthotopic living donor liver transplantation in a patient with alcoholic liver cirrhosis to overcome donor steatosis. Transpl Int, 2006, 19(5): 424-429.
18. 朱志軍, 魏林, 張海明, 等. 小體積移植物輔助性肝移植治療門靜脈高壓癥的臨床效果. 中華外科雜志, 2023, 61(3): 220-226.
19. 中華醫學會器官移植學分會, 中國醫師協會器官移植醫師分會. 中國活體肝移植供者微創手術技術指南(2024年版). 中國普外基礎與臨床雜志, 2024, 31(3): 285-296.
20. Ge J, Perito ER, Bucuvalas J, et al. Split liver transplantation is utilized infrequently and concentrated at few transplant centers in the United States. Am J Transplant, 2020, 20(4): 1116-1124.
21. Hu TH, Chen CL, Lin CC, et al. Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation. Transplantation, 2014, 97 Suppl 8: S53-S59.
22. Mehrabi A, Esmaeilzadeh M, Fonouni H, et al. The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation. Langenbecks Arch Surg, 2012, 397(5): 697-710.
23. Wang SF, Chen XP, Chen ZS, et al. Left lobe auxiliary liver transplantation for end-stage hepatitis B liver cirrhosis. Am J Transplant, 2017, 17(6): 1606-1612.
24. Wei L, Zhang HM, Wan CD, et al. Auxiliary liver graft can be protected from HBV infection in HBsAg positive blood circulation. Front Med (Lausanne), 2021, 8: 726502. doi: 10.3389/fmed.2021.726502.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Clinical application value of small-for-size left lobe liver auxiliary partial orthotopic liver transplantation for treatment of decompensated cirrhosis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content